JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

First published online April 16, 2009, 10.2967/jnumed.108.061697
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.108.061697v1
50/5/833    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eterovic, D.
Right arrow Articles by Antunovic, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eterovic, D.
Right arrow Articles by Antunovic, Z.
Journal of Nuclear Medicine Vol. 50 No. 5 833-834
© 2009 by Society of Nuclear Medicine
doi: 10.2967/jnumed.108.061697

131I Radiation Dose Distribution in Metastases of Thyroid Carcinoma

Davor Eterovic, Vinko Markovic, Ante Punda and Zeljko Antunovic

University of Split
Split, Croatia

TO THE EDITOR: We would like to comment on the article of Champion et al. (1), who applied the Monte Carlo method to assess electron dose distributions both inside and outside small water spheres uniformly filled with 131I. Although others have done the same before, Champion et al. emphasized the important issue of the decaying radial gradient of electron dose inside the spheres of sizes comparable to the ranges of 131I β-radiation. This prompts us to conclude that cancer cells at the periphery of small metastases would receive less radiation than would cells near the center.

We accept this conclusion but emphasize that iodine is not distributed uniformly within the thyroid tissue or, probably, within the metastases of thyroid carcinoma either. Iodine spends most of its intrathyroidal life bound to thyroglobulin molecules, segregated in the colloidal lumina of thyroid follicles—that is, extracellularly. The self-absorption of β-radiation in colloidal lumina decreases the radiation dose to thyroid cells. Our simulation showed that thyroid cells comprising a colloidal sphere 250 µm in radius would receive about 85% of an average electron radiation dose to the thyroid (2). This effect does not depend on the size of a metastasis but on whether it has a follicular structure and how large the follicles are. Bearing in mind that a thyroid ultrasound image reflects the follicular structure (3), the histology-specific inhomogeneity of intrathyroidal electron dose distribution may be, at least in part, responsible for the greater radiosensitivity of hypoechogenic thyroids (small follicles) than of the normoechogenic thyroids (large follicles) of patients with Graves disease (4).

More recently, Champion et al. have also capitalized on the issue of thyroid microstructure but obtained results that differ from our results (5), which we will comment on separately.

We conclude that, beyond the radioiodine uptake and its effective half-life, both the size of a metastasis and its structure determine the 131I radiation dose to target cells.

FOOTNOTES

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

References

  1. Champion C, Zanotti-Fregonara P, Hindié E. CELLDOSE: a Monte Carlo code to assess electron dose distribution—S values for 131I in spheres of various sizes. J Nucl Med. 2008;49:151–157.[Abstract/Free Full Text]
  2. Eterovic D, Antunovic Z, Markovic V, Grosev D. Planning of 131I therapy for Graves disease based on the radiation dose to thyroid follicular cells. J Nucl Med. 2008;49:2026–2030.[Abstract/Free Full Text]
  3. Muller HW, Shroder S, Schneider C, Seiffert G. Sonographic tissue characterisation in thyroid gland diagnosis: a correlation between sonography and hystology. Klin Wochenschr. 1985;63:706–710.[CrossRef][Medline]
  4. Markovic V, Eterovic D. Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves' disease. J Clin Endocrinol Metab. 2007;92:3547–3552.[Abstract/Free Full Text]
  5. Hindié E, Champion C, Zanotti-Fregonara P, et al. Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE." Eur J Nucl Med Mol Imaging. 2009;36:130–136.[CrossRef][Medline]




This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.108.061697v1
50/5/833    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eterovic, D.
Right arrow Articles by Antunovic, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eterovic, D.
Right arrow Articles by Antunovic, Z.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE